2023 Review: Chinese-Sponsored Phase III US Trials See Uptick
But Still Below '21 Level
Companies from China single-handedly sponsored a total of eight Phase III clinical studies that included US sites in 2023 compared to six in 2022 - but the figure was still below the record of 11 in 2021.
